Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trialShoujie Huang, Ningshao Xia, Xiaowen Hu et al.|The Lancet|2024Cited by 70
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYuemei Hu, Ningshao Xia, Zhaofeng Bi et al.|Science Bulletin|2023Cited by 26
Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathwayJia Luo, Yue Huang|Aging|2021Cited by 20
Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern ChinaXingcheng Huang, Ningshao Xia, Xiaoxiang Zheng et al.|Emerging Microbes & Infections|2024Cited by 11